摘要
目的研究神经阻滞疗法复合抗骨质疏松治疗对慢性腰腿痛的治疗效果,以及对骨密度的影响,评价这种复合治疗的安全性.方法慢性腰腿痛病人120例,其中骨质疏松40例.骨质疏松患者分成神经阻滞+抗骨质疏松(NB+AO,n=22)组和抗骨质疏松组(AO,n=18).其余80例患者只采用神经阻滞疗法(NB)组.治疗后6～9个月、9～12个月随访患者的骨密度.结果绝大部分NB组和NB+AO组的患者疼痛明显缓解,单纯抗骨质疏松治疗的A0组疼痛缓解不明显;NB+AO组的骨质疏松患者骨密度未见下降(P＞0.05).结论神经阻滞疗法治疗患有骨质疏松的慢性腰腿痛患者时,辅助抗骨质疏松治疗可使这些患者的骨密度不进一步下降,保证镇痛疗效的同时,提高了治疗的安全性.
Objectives To evaluate the effect of the nerve block combined with anti- osteoporosis on the patients with low back pain and osteoporosis. Methods Of one hundred and twenty patients, were included in this study, forty patients who were diagnosed as osteoporosis by DEXA were divided into group NB＋AO and group AO. Patients in the NB＋AO first group （n=22） were given nerve block for their pain and medicines to improve bone mineral density （BMD）. Whereas those in the laterAO group （n=18） were administered with medicines only. The other 80 patients without osteoporosis were treated by nerve block to control their low back pain. Results Patients with nerve block no matter combined with anti-osteoporosis or not got better pain relief than those without nerve block （P〈0.01）. Medicines which improvesd osteoporosis could prevent loss of bone mineral during pain management by nerve block in patients with osteoporosis. Conclusions It wiII be effective and safe when patients with low back pain and osteoporosis treated with nerve block accompanied with medicine which improve osteoporosis.
出处
《老年医学与保健》
CAS
2005年第3期163-164,176,共3页
Geriatrics & Health Care
